Your browser doesn't support javascript.
Clinical and molecular characterization of COVID-19 hospitalized patients.
Benetti, Elisa; Giliberti, Annarita; Emiliozzi, Arianna; Valentino, Floriana; Bergantini, Laura; Fallerini, Chiara; Anedda, Federico; Amitrano, Sara; Conticini, Edoardo; Tita, Rossella; d'Alessandro, Miriana; Fava, Francesca; Marcantonio, Simona; Baldassarri, Margherita; Bruttini, Mirella; Mazzei, Maria Antonietta; Montagnani, Francesca; Mandalà, Marco; Bargagli, Elena; Furini, Simone; Renieri, Alessandra; Mari, Francesca.
  • Benetti E; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Giliberti A; Medical Genetics, University of Siena, Siena, Italy.
  • Emiliozzi A; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Valentino F; Department of Specialized and Internal Medicine, Tropical and Infectious Diseases Unit, Azienda Ospedaliera Universitaria Senese, Senese, Italy.
  • Bergantini L; Medical Genetics, University of Siena, Siena, Italy.
  • Fallerini C; Unit of Respiratory Diseases and Lung Transplantation, Department of Internal and Specialist Medicine, University of Siena, Siena, Italy.
  • Anedda F; Medical Genetics, University of Siena, Siena, Italy.
  • Amitrano S; Department of Emergency and Urgency, Medicine, Surgery and Neurosciences, Unit of Intensive Care Medicine, Siena University Hospital, Siena, Italy.
  • Conticini E; Genetica Medica, Azienda Ospedaliera Universitaria Senese, Senese, Italy.
  • Tita R; Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Policlinico Le Scotte, Siena, Italy.
  • d'Alessandro M; Genetica Medica, Azienda Ospedaliera Universitaria Senese, Senese, Italy.
  • Fava F; Unit of Respiratory Diseases and Lung Transplantation, Department of Internal and Specialist Medicine, University of Siena, Siena, Italy.
  • Marcantonio S; Medical Genetics, University of Siena, Siena, Italy.
  • Baldassarri M; Genetica Medica, Azienda Ospedaliera Universitaria Senese, Senese, Italy.
  • Bruttini M; Department of Emergency and Urgency, Medicine, Surgery and Neurosciences, Unit of Intensive Care Medicine, Siena University Hospital, Siena, Italy.
  • Mazzei MA; Medical Genetics, University of Siena, Siena, Italy.
  • Montagnani F; Medical Genetics, University of Siena, Siena, Italy.
  • Mandalà M; Genetica Medica, Azienda Ospedaliera Universitaria Senese, Senese, Italy.
  • Bargagli E; Department of Medical, Surgical and Neuro Sciences and Radiological Sciences, Unit of Diagnostic Imaging, University of Siena, Azienda Ospedaliera Universitaria Senese, Senese, Italy.
  • Furini S; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Renieri A; Otolaryngology Unit, University of Siena, Siena, Italy.
  • Mari F; Unit of Respiratory Diseases and Lung Transplantation, Department of Internal and Specialist Medicine, University of Siena, Siena, Italy.
PLoS One ; 15(11): e0242534, 2020.
Article in English | MEDLINE | ID: covidwho-934336
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
Clinical and molecular characterization by Whole Exome Sequencing (WES) is reported in 35 COVID-19 patients attending the University Hospital in Siena, Italy, from April 7 to May 7, 2020. Eighty percent of patients required respiratory assistance, half of them being on mechanical ventilation. Fiftyone percent had hepatic involvement and hyposmia was ascertained in 3 patients. Searching for common genes by collapsing methods against 150 WES of controls of the Italian population failed to give straightforward statistically significant results with the exception of two genes. This result is not unexpected since we are facing the most challenging common disorder triggered by environmental factors with a strong underlying heritability (50%). The lesson learned from Autism-Spectrum-Disorders prompted us to re-analyse the cohort treating each patient as an independent case, following a Mendelian-like model. We identified for each patient an average of 2.5 pathogenic mutations involved in virus infection susceptibility and pinpointing to one or more rare disorder(s). To our knowledge, this is the first report on WES and COVID-19. Our results suggest a combined model for COVID-19 susceptibility with a number of common susceptibility genes which represent the favorite background in which additional host private mutations may determine disease progression.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Exome Sequencing / COVID-19 / Hospitalization Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2020 Document Type: Article Affiliation country: Journal.pone.0242534

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Exome Sequencing / COVID-19 / Hospitalization Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2020 Document Type: Article Affiliation country: Journal.pone.0242534